NYSE:BAX - Baxter International Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $66.51 +0.68 (+1.03 %) (As of 11/18/2018 04:00 PM ET)Previous Close$66.51Today's Range$65.3956 - $66.9152-Week Range$61.05 - $78.38Volume7.51 million shsAverage Volume5.02 million shsMarket Capitalization$35.39 billionP/E Ratio26.82Dividend Yield1.14%Beta1.02 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Baxter International Inc. provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. It offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. The company also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and by patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois. Receive BAX News and Ratings via Email Sign-up to receive the latest news and ratings for BAX and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNYSE:BAX Previous Symbol CUSIP07181310 Webwww.baxter.com Phone224-948-2000 Debt Debt-to-Equity Ratio0.38 Current Ratio2.60 Quick Ratio1.96 Price-To-Earnings Trailing P/E Ratio26.82 Forward P/E Ratio22.17 P/E Growth1.79 Sales & Book Value Annual Sales$10.56 billion Price / Sales3.35 Cash Flow$3.9216 per share Price / Cash16.96 Book Value$17.13 per share Price / Book3.88 Profitability EPS (Most Recent Fiscal Year)$2.48 Net Income$717 million Net Margins10.90% Return on Equity17.67% Return on Assets9.49% Miscellaneous Employees47,000 Outstanding Shares532,140,000Market Cap$35.39 billion OptionableOptionable Baxter International (NYSE:BAX) Frequently Asked Questions What is Baxter International's stock symbol? Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX." How often does Baxter International pay dividends? What is the dividend yield for Baxter International? Baxter International announced a quarterly dividend on Tuesday, November 13th. Stockholders of record on Monday, December 3rd will be given a dividend of $0.19 per share on Wednesday, January 2nd. This represents a $0.76 dividend on an annualized basis and a dividend yield of 1.14%. The ex-dividend date is Friday, November 30th. View Baxter International's Dividend History. How will Baxter International's stock buyback program work? Baxter International declared that its Board of Directors has approved a share repurchase plan on Tuesday, November 13th 2018, which authorizes the company to repurchase $2,000,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase up to 6.1% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company's leadership believes its shares are undervalued. How were Baxter International's earnings last quarter? Baxter International Inc (NYSE:BAX) released its quarterly earnings data on Wednesday, October, 31st. The medical instruments supplier reported $0.80 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.74 by $0.06. The medical instruments supplier earned $2.77 billion during the quarter, compared to analysts' expectations of $2.79 billion. Baxter International had a net margin of 10.90% and a return on equity of 17.67%. The company's revenue for the quarter was up 2.2% compared to the same quarter last year. During the same quarter last year, the firm posted $0.64 earnings per share. View Baxter International's Earnings History. When is Baxter International's next earnings date? Baxter International is scheduled to release their next quarterly earnings announcement on Thursday, February 7th 2019. View Earnings Estimates for Baxter International. What guidance has Baxter International issued on next quarter's earnings? Baxter International updated its fourth quarter earnings guidance on Wednesday, October, 31st. The company provided earnings per share (EPS) guidance of $0.71-0.73 for the period, compared to the Thomson Reuters consensus estimate of $0.77. Baxter International also updated its FY 2018 guidance to $2.98-3.00 EPS. What price target have analysts set for BAX? 15 analysts have issued 1 year price targets for Baxter International's shares. Their predictions range from $66.00 to $85.00. On average, they expect Baxter International's stock price to reach $74.00 in the next twelve months. This suggests a possible upside of 11.3% from the stock's current price. View Analyst Price Targets for Baxter International. What is the consensus analysts' recommendation for Baxter International? 15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 2 sell ratings, 3 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Baxter International. Has Baxter International been receiving favorable news coverage? News coverage about BAX stock has been trending neutral recently, InfoTrie reports. InfoTrie scores the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Baxter International earned a coverage optimism score of 0.2 on InfoTrie's scale. They also assigned news coverage about the medical instruments supplier a news buzz of 9.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the near future. Who are some of Baxter International's key competitors? Some companies that are related to Baxter International include 3M (MMM), Becton Dickinson and (BDX), Stryker (SYK), Boston Scientific (BSX), FRESENIUS SE &/S (FSNUY), ResMed (RMD), ABIOMED (ABMD), DexCom (DXCM), Teleflex (TFX), Hill-Rom (HRC), Haemonetics (HAE), Globus Medical (GMED), ICU Medical (ICUI), Insulet (PODD) and Penumbra (PEN). Who are Baxter International's key executives? Baxter International's management team includes the folowing people: Mr. José E. Almeida, Chairman, Pres & CEO (Age 56)Mr. James K. Saccaro, Exec. VP & CFO (Age 45)Mr. Sean Martin, Sr. VP & Gen. Counsel (Age 55)Mr. Brik V. Eyre, Sr. VP & Pres of Americas (Age 54)Mr. Giuseppe Accogli, Sr. VP & Pres of Global Bus.es (Age 47) Who are Baxter International's major shareholders? Baxter International's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (7.41%), FMR LLC (5.52%), AQR Capital Management LLC (1.26%), Standard Life Aberdeen plc (1.08%), Veritas Asset Management LLP (0.89%) and Janus Henderson Group PLC (0.81%). Company insiders that own Baxter International stock include Albert P L Stroucken, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International. Which institutional investors are selling Baxter International stock? BAX stock was sold by a variety of institutional investors in the last quarter, including Veritas Asset Management LLP, BlackRock Inc., Wells Fargo & Company MN, Point72 Asset Management L.P., Mitsubishi UFJ Trust & Banking Corp, TIAA CREF Investment Management LLC, The Manufacturers Life Insurance Company and Acadian Asset Management LLC. Company insiders that have sold Baxter International company stock in the last year include Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, Peter S Hellman and Scott Pleau. View Insider Buying and Selling for Baxter International. Which institutional investors are buying Baxter International stock? BAX stock was purchased by a variety of institutional investors in the last quarter, including Standard Life Aberdeen plc, Schroder Investment Management Group, FMR LLC, Prudential Financial Inc., Thrivent Financial for Lutherans, Man Group plc, Janus Henderson Group PLC and Stevens Capital Management LP. View Insider Buying and Selling for Baxter International. How do I buy shares of Baxter International? Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Baxter International's stock price today? One share of BAX stock can currently be purchased for approximately $66.51. How big of a company is Baxter International? Baxter International has a market capitalization of $35.39 billion and generates $10.56 billion in revenue each year. The medical instruments supplier earns $717 million in net income (profit) each year or $2.48 on an earnings per share basis. Baxter International employs 47,000 workers across the globe. What is Baxter International's official website? The official website for Baxter International is http://www.baxter.com. How can I contact Baxter International? Baxter International's mailing address is One Baxter Parkway, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected] MarketBeat Community Rating for Baxter International (NYSE BAX)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 556 (Vote Outperform)Underperform Votes: 493 (Vote Underperform)Total Votes: 1,049MarketBeat's community ratings are surveys of what our community members think about Baxter International and other stocks. Vote "Outperform" if you believe BAX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BAX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 11/18/2018 by MarketBeat.com StaffFeatured Article: What does cost of debt say about a company’s financial health?